Advertisement
Screener

PAR PHARMACEUTICAL COMPANIES, INC. Increase (Decrease) in Other Accounts Payable

PAR PHARMACEUTICAL COMPANIES, INC. Increase (Decrease) in Other Accounts Payable

PAR PHARMACEUTICAL COMPANIES, INC. reported Increase (Decrease) in Other Accounts Payable of -$12.62 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2015-08-06

  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in other accounts payable for the quarter ending 2015-06-30 was -$4.23M.
  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in other accounts payable for the quarter ending 2015-03-31 was -$8.39M.
  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in other accounts payable for the quarter ending 2014-09-30 was -$10.16M, a 234.57% decline year-over-year.
  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in other accounts payable for the quarter ending 2014-06-30 was -$2.11M.
  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in other accounts payable for fiscal 2011 was $43.26M.
  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in other accounts payable for fiscal 2010 was -$33.24M.
  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in other accounts payable for fiscal 2009 was -$32.90M.
Period endIncrease (Decrease) in Other Accounts Payable 3 monthIncrease (Decrease) in Other Accounts Payable 6 monthIncrease (Decrease) in Other Accounts Payable 9 monthIncrease (Decrease) in Other Accounts Payable 12 month
2015-06-30-$4.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$12.62M
10-Q · filed 2015-08-06
2015-03-31-$8.39M
10-Q · filed 2015-05-11
2014-09-30-$10.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
-$12.27M
derived: sum of 2 quarters · filed 2015-08-06
-$24.38M
10-Q · filed 2014-11-12
2014-06-30-$2.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$14.21M
10-Q · filed 2015-08-06
2014-03-31-$12.10M
10-Q · filed 2015-05-11
2013-09-30$7.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
-$30.44M
derived: sum of 2 quarters · filed 2014-11-12
$5.66M
10-Q · filed 2014-11-12
2013-06-30-$37.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
-$1.89M
10-Q · filed 2014-08-11
2013-03-31$36.10M
10-Q · filed 2014-05-15
2012-06-30-$8.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
-$4.39M
10-Q · filed 2012-08-02
$10.71M
derived: sum of 3 quarters · filed 2012-08-02
$13.75M
derived: sum of 4 quarters · filed 2012-08-02
2012-03-31$3.84M
10-Q · filed 2012-05-08
$18.95M
derived: sum of 2 quarters · filed 2012-05-08
$21.98M
derived: sum of 3 quarters · filed 2012-05-08
$40.97M
derived: sum of 4 quarters · filed 2012-08-02
2011-12-31$15.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$18.14M
derived: sum of 2 quarters · filed 2012-02-28
$37.13M
derived: sum of 3 quarters · filed 2012-08-02
$43.26M
10-K · filed 2012-02-28
2011-09-30$3.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
$22.03M
derived: sum of 2 quarters · filed 2012-08-02
$28.16M
10-Q · filed 2011-11-02
$28.10M
derived: sum of 4 quarters · filed 2012-08-02
2011-06-30$18.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
$25.13M
10-Q · filed 2012-08-02
$25.06M
derived: sum of 3 quarters · filed 2012-08-02
$5.99M
derived: sum of 4 quarters · filed 2012-08-02
2011-03-31$6.14M
10-Q · filed 2012-05-08
$6.08M
derived: sum of 2 quarters · filed 2012-05-08
-$13.00M
derived: sum of 3 quarters · filed 2012-05-08
-$17.95M
derived: sum of 4 quarters · filed 2012-05-08
2010-12-31-$61.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
-$19.13M
derived: sum of 2 quarters · filed 2012-02-28
-$24.09M
derived: sum of 3 quarters · filed 2012-02-28
-$33.24M
10-K · filed 2012-02-28
2010-09-30-$19.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
-$24.03M
derived: sum of 2 quarters · filed 2011-11-02
-$33.18M
10-Q · filed 2011-11-02
2010-06-30-$4.95M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-08-03
-$14.11M
10-Q · filed 2011-08-03
2010-03-31-$9.15M
10-Q/A · filed 2011-05-06
2009-12-31-$32.90M
10-K · filed 2012-02-28